UBE2W and breast cancer: Several datasets showed high expression levels of UBE2W was significantly in cancer samples verse in normal samples, including breast cancer (BRCA), head and neck cancers (HNSC), lymphoma, colorectal cancer, melanoma (Supplementary Table 1).